Tesaglitazar, a dual peroxisome proliferator-activated receptor α/γ agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
暂无分享,去创建一个
B. Fagerberg | S. Tonstad | I. Gause-Nilsson | S. Stender | S. Halldorsdottir | H. Schuster | S. Edwards | T. Halmos | J. Lopatyński | G. Birketvedt | K. Öhman